Merit Medical Systems EBITDA 2011-2025 | MMSI
Merit Medical Systems annual and quarterly EBITDA history from 2011 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Merit Medical Systems EBITDA for the quarter ending September 30, 2025 was $0.078B, a 14.9% increase year-over-year.
- Merit Medical Systems EBITDA for the twelve months ending September 30, 2025 was $0.305B, a 14.2% increase year-over-year.
- Merit Medical Systems 2024 annual EBITDA was $0.277B, a 22.15% increase from 2023.
- Merit Medical Systems 2023 annual EBITDA was $0.227B, a 25.85% increase from 2022.
- Merit Medical Systems 2022 annual EBITDA was $0.18B, a 14.67% increase from 2021.
|
Merit Medical Systems Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $277 |
| 2023 | $227 |
| 2022 | $180 |
| 2021 | $157 |
| 2020 | $106 |
| 2019 | $120 |
| 2018 | $129 |
| 2017 | $87 |
| 2016 | $79 |
| 2015 | $76 |
| 2014 | $77 |
| 2013 | $61 |
| 2012 | $52 |
| 2011 | $52 |
| 2010 | $32 |
|
Merit Medical Systems Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-09-30 | $78 |
| 2025-06-30 | $82 |
| 2025-03-31 | $75 |
| 2024-12-31 | $70 |
| 2024-09-30 | $68 |
| 2024-06-30 | $74 |
| 2024-03-31 | $64 |
| 2023-12-31 | $61 |
| 2023-09-30 | $62 |
| 2023-06-30 | $54 |
| 2023-03-31 | $50 |
| 2022-12-31 | $54 |
| 2022-09-30 | $42 |
| 2022-06-30 | $46 |
| 2022-03-31 | $38 |
| 2021-12-31 | $46 |
| 2021-09-30 | $40 |
| 2021-06-30 | $33 |
| 2021-03-31 | $39 |
| 2020-12-31 | $43 |
| 2020-09-30 | $27 |
| 2020-06-30 | $8 |
| 2020-03-31 | $28 |
| 2019-12-31 | $23 |
| 2019-09-30 | $24 |
| 2019-06-30 | $38 |
| 2019-03-31 | $35 |
| 2018-12-31 | $33 |
| 2018-09-30 | $39 |
| 2018-06-30 | $33 |
| 2018-03-31 | $24 |
| 2017-12-31 | $28 |
| 2017-09-30 | $15 |
| 2017-06-30 | $26 |
| 2017-03-31 | $18 |
| 2016-12-31 | $25 |
| 2016-09-30 | $15 |
| 2016-06-30 | $22 |
| 2016-03-31 | $18 |
| 2015-12-31 | $18 |
| 2015-09-30 | $18 |
| 2015-06-30 | $22 |
| 2015-03-31 | $18 |
| 2014-12-31 | $24 |
| 2014-09-30 | $21 |
| 2014-06-30 | $16 |
| 2014-03-31 | $15 |
| 2013-12-31 | $20 |
| 2013-09-30 | $17 |
| 2013-06-30 | $15 |
| 2013-03-31 | $10 |
| 2012-12-31 | $10 |
| 2012-09-30 | $15 |
| 2012-06-30 | $14 |
| 2012-03-31 | $13 |
| 2011-12-31 | $11 |
| 2011-09-30 | $11 |
| 2011-06-30 | $15 |
| 2011-03-31 | $15 |
| 2010-12-31 | $10 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $5.191B | $1.357B |
| Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $105.158B | 23.49 |
| Becton Dickinson (BDX) | United States | $50.974B | 12.33 |
| Cardinal Health (CAH) | United States | $48.391B | 22.86 |
| West Pharmaceutical Services (WST) | United States | $19.500B | 38.34 |
| Straumann Holding AG (SAUHY) | Switzerland | $19.310B | 0.00 |
| Cooper (COO) | United States | $13.937B | 17.44 |
| Align Technology (ALGN) | United States | $9.675B | 18.27 |
| Henry Schein (HSIC) | United States | $8.464B | 14.92 |
| DENTSPLY SIRONA (XRAY) | United States | $2.230B | 7.08 |
| CONMED (CNMD) | United States | $1.361B | 9.73 |
| STAAR Surgical (STAA) | United States | $1.321B | 0.00 |
| Pro-Dex (PDEX) | United States | $0.101B | 12.04 |
| Lifevantage (LFVN) | United States | $0.094B | 8.92 |